600062.SHG · China Resources Double-Crane Pharmaceutical Co.,Ltd

China Resources Double-Crane Pharmaceutical Co.,Ltd is currently in a long term downtrend where the price is trading 2.3% below its 200 day moving average.

From a valuation standpoint, the stock is 85.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.4.

China Resources Double-Crane Pharmaceutical Co.,Ltd's total revenue rose by 7.9% to $2B since the same quarter in the previous year.

Its net income has dropped by 3.4% to $132M since the same quarter in the previous year.

Finally, its free cash flow grew by 43.0% to $186M since the same quarter in the previous year.

Based on the above factors, China Resources Double-Crane Pharmaceutical Co.,Ltd gets an overall score of 3/5.